Triggering of effector functions on a CD8+ T cell clone upon the aggregation of an activatory CD94/kp39 heterodimer

Journal of Immunology

Volumn 162, Issue 7, 1999, Pages 3996-4002

  Bellón, Teresa ^a   De Heredia, Agustín B ^b   Llano, Manuel ^a   Minguela, Alfredo ^c   Rodriguez, Antonio ^a   López Botet, Miguel ^a   Aparicio, Pedro ^b,d  

^a HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

^b UNIVERSITY OF MURCIA   (Spain)

^c HOSPITAL UNIVERSITARIO VIRGEN DE LA ARRIXACA   (Spain)

^d UNIVERSITY OF MURCIA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CD2 ANTIGEN; CD28 ANTIGEN; CD45 ANTIGEN; CD69 ANTIGEN; CD8 ANTIGEN; CD94 ANTIGEN; GAMMA INTERFERON;

ANTIGEN EXPRESSION; ARTICLE; CALCIUM CELL LEVEL; CROSS LINKING; CYTOTOXICITY; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; INTERFERON PRODUCTION; LYMPHOCYTE CLONE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION;

AMINO ACID SEQUENCE; ANIMALS; ANTIGENS, CD; ANTIGENS, CD3; ANTIGENS, CD94; CALCIUM; CD8-POSITIVE T-LYMPHOCYTES; CELL LINE, TRANSFORMED; CLONE CELLS; CYTOTOXICITY, IMMUNOLOGIC; DIMERIZATION; HUMANS; INTERFERON TYPE II; LECTINS, C-TYPE; LYMPHOCYTE ACTIVATION; MEMBRANE GLYCOPROTEINS; MOLECULAR SEQUENCE DATA; RECEPTOR AGGREGATION; RECEPTORS, IMMUNOLOGIC; RECEPTORS, INTERLEUKIN-2;

EID: 0033120070     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Moretta, A., R. Biassoni, C. Bottino, D. Pende, M. Vitale, A. Poggi, M. C. Mingari, and L. Moretta. 1997. Major histocompatibility complex class I-specific receptors on human natural killer and T lymphocytes. Immunol. Rev. 155:105.
2. Bendelac, A. 1997. Selection and adaptation of cells expressing major histocompatibility complex class-I-specific receptors of the natural killer complex. J. Exp. Med. 186:349.
3. Rolstad, B., J. T. Vaage, C. Naper, D. Lambracht, K. Wonigeit, E. Joly, and G. W. Butcher. 1997. Positive and negative MHC class-I recognition by rat NK cells. Immunol. Rev. 155:91.
4. Lanier, L. L., B. Corliss, and J. H. Philips. 1997. Arousal and inhibition of human NK cells. Immunol. Rev. 155:145.
5. Colonna, M. 1997. Specificity and function of immunoglobulin superfamily NK cell inhibitory and stimulatory receptors. Immunol. Rev. 155:127.
6. Renard, V., A. Cambiaggi, F. Véli, M. Bléry, L. Olcese, S. Olivero, M. Bouchet, and E. Vivier. 1997. Transduction of cytotoxic signals in natural killer cells: a general model of fine tuning between activatory and inhibitory pathways in lymphocytes. Immunol. Rev. 155:205.
7. Lanier, L. L., B. C. Corliss, J. Wu, C. Leong, and J. H. Phillips. 1998. Immunoreceptor DAP12 bearing a tyrosine-based activation motif is involved in activating NK cells. Nature 391:703.
8. López-Botet, M., J. J. Pérez-Villar, M. Carretero, A. Rodríguez, Y. Melero, T. Bellón, M. Llano, and F. Navarro. 1997. Structure and function of the CD94 C-type lectin receptor complex involved in recognition of HLA class I molecule. Immunol. Rev. 155:165.
9. Carretero, M., C. Cantoni, T. Bellón, C. Bottino, R. Biassoni, A. Rodriguez, J. J. Pérez-Villar, L. Moretta, A. Moretta, and M. López Botet. 1997. The CD94 and NKG2-A C-type lectins covalently assemble to form a NK cell inhibitory receptor for HLA class-I molecules. Eur. J. Immunol. 27:563.
10. Brooks, A. G., P. E. Posch, C. J. Scorzelli, F. Borrego, and J. E. Coligan, 1997. NKG2A complexed with CD94 defines a novel inhibitory natural killer cell receptor. J. Exp. Med. 185:795.
11. Houchins, J. P., L. L. Lanier, E. C. Niemi, J. H. Phillips, and J. C. Ryan. 1997. Natural killer cell cytolytic activity is inhibited by NKG2-A and activated by NKG2-C. J. Immunol. 158:3603.
12. Braud, V. M., D. S. J. Allan, C. A. O'Callaghan, K. Söderström, A. D'Andrea, G. S. Ogg, S. Lazetic, N. T. Young, J. I. Bell, J. H. Phillips, L. L. Lanier, and A. J. McMichael. 1998. HLA-E binds to natural killer cell receptors CD94/ NKG2A, B and C. Nature 391:795.
13. Lee, N., M. Llano, M. Carretero, A. Ishitani, P. Navarro, M. López-Botet, and D. E. Geraghty. 1998. HLA-E is a major ligand for the inhibitory receptor CD94/ NKG2A. Proc. Natl. Acad. Sci. USA 95:5199.
14. Llano M., N. Lee, F. Navarro, P. García, J. P. Albar, D. E. Geraghty, and M. López Botet. 1998. HLA-E-bound peptides influence recognition by inhibitory and triggering CD94/NKG2 receptors: preferential response to an HLA-G-derived nonamer. Eur. J. Immunol. 28:2584.
15. Phillips, J. H., J. E. Gumperz, P. Parham, and L. L. Lanier. 1995. Superantigen-dependent, cell mediated cytotoxicity inhibited by MHC class I receptors on T lymphocytes. Science 268:403.
16. Ferrini, S., A. Cambiaggi, R. Meazza, S. Sforzini, S. Marciano, L. C. Mingari, and L. Moretta. 1994. T cell clones expressing the natural killer cell-related p58 receptor molecule display heterogeneity in phenotypic properties and p58 function. Eur. J. Immunol. 24:2294.
17. Mandelboim, O., D. M. Davis, H. T. Reyburn, M. Valés-Gómez, E. G. Sheu, L. Pazmany, and J. L. Strominger. 1996 Enhacement of class II-restricted T cells responses by costimulatory NK receptors for MHC class I MHC proteins. Science 274:2097.
18. Mandelboim, O., S. Kent, D. M. Davis, S. B. Wilson, T. Okazaki, R. Jackson, D. Hafler, and J. L. Strominger. 1998. Natural killer activating receptors trigger interferon γ secretion from T cells and natural killer cells. Proc. Natl. Acad. Sci. USA 95:3798.
19. De Vries J. E., and H. Spitz. 1984. Cloned human cytotoxic T lymphocyte (CTL) lines reactive with autologous melanoma cells. I. In vitro generation, isolation, and analysis of phenotype and specificity. J. Immunol. 132:510.
20. Hernández-Caselles T., M. Martínez-Esparza, A. I. Lazarovitz, and P. Aparicio. 1996. Specific regulation of VLA-4 and α4β7 integrin expression on human activated T lymphocytes. J. Immunol. 156:3668.
21. Hernández-Caselles T., G. Rubio, M. R. Campanero, M. A. del Pozo, M. Muro, F. Sánchez-Madrid, and P. Aparicio. 1993. ICAM-3, the third LFA-I counterreceptor, is a co-stimulatory molecule for both resting and activated lymphocytes. Eur. J. Immunol. 23:2799.
22. Aramburu, J., M. A. Balboa, A. Ramírez, A Silva, A. Acevedo, F. Sánchez-Madrid, M. O. de Landázuri, and M. López-Botet. 1990. A novel functional cell surface dimer (Kp43) expressed by natural killer and T cell receptor γδ T lymphocytes. J. Immunol. 144:3238.
23. Sivory S., M. Vitale, C. Bottino, E. Marcenato, L. Sanseverino, S. Parolini, L. Moretta, and A. Moretta. 1996. CD94 functions as a natural killer cell inhibitory receptor for different HLA class-I alleles: identification of the inhibitory form of CD94 by the use of novel monoclonal antibodies. Eur. J. Immunol. 26:2487.
24. Colonna, M., F. Navarro, T. Bellón, M. Llano, P. García, J. Samarifdis, L. Angman, M. Cella, and M. López-Botet. 1997. A common inhibitory receptor for major histocompatibility complex class I molecules on human lymphoid and myelomonocytic cells. J. Exp. Med. 11:1809.
25. Rubio, G., J. Aramburu, J. Ontañón, M. López-Botet, and P. Aparicio. 1993. A novel functional cell surface dimer (Kp43) serves as a accessory molecule for the activation of a subset of human γδ T cells. J. Immunol. 151:1312.
26. López-Rivas A., S. A. Mendoza, E. Nänberg, J. Sinnett, A. Smith, and E. Rozengert. 1987. Ca++ mobilizing actions of platelet-derived growth factor differ from those of bombesin and vasopressin in Swiss ST3 mock cells. Proc. Natl. Acad. Sci USA 84:5768.
27. Chomszynski P., and N. Sacchi. 1987. Single-step method of RNA isolation by acidic guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:156.
28. Pérez-Villar J. J., M. Carretero, F. Navarro, I. Melero, A. Rodríguez, C. Bottino, A. Moretta, and M. López-Botet. 1996. Biochemical and serological evidence for the existence of functionally distinct forms of the CD94 NK cell receptor. J. Immunol. 157:5367.
29. Carena, I., A. Shamshiev, A. Donda, M. Colonna, and G. De Libero. 1997. Major histocompatibility complex class I molecules modulate activation threshold and early signaling of T cell antigen receptor-γ/δ stimulated by nonpeptidic ligands. J. Exp. Med. 186:1769.
30. Borrego, F., M. Ulbrecht, E. H. Weiss, J. E. Coligan, and A. G. Brooks. 1998. Recognition of human histocompatibility leukocyte antigen (HLA-E) complexed with HLA class signal sequence-derived peptides by CD94/NKG2 confers protection from natural killer cell-mediated lysis. J. Exp. Med. 187:813.
31. Glienke J., Y. Sobanov, C. Brostjan, C. Steffens, C. Nguyen, H. Lehrach, E. Hofer, and F. Francis. 1998. The genomic organization of NKG2 C, E, F and D receptor genes in the human natural killer gene complex. Immunogenetics 48:163.
32. Lanier, L. L., B. C. Corliss, J. Wu, and J. H. Phillips. 1998. Association of DAP-12 with activatory CD94/NKG2C NK cell receptor. Immunity 8:693.
33. Battistini L., G. Borsellino, G. Sawicki, F. Poccia, M. Salvetti, G. Ristori, and C. F. Brosnan. 1997. Phenotypic and cytokine analysis of human peripheral blood γδ T cells expressing NK cell receptors. J. Immunol. 159:3723.
34. Medzhitov R., and C. A. Janeway Jr. 1997. Innate immunity impact on the adaptive immune response. Curr. Opin. Immunol. 9:4.
35. Reyburn, H. T., O. Mandelboim, M. Valés-Gómez, M. D. M. Davis, L. Pazmany, and J. Strominger. 1997 The class I MHC homologue of human cytomegalovirus inhibits attack by natural killer cells. Nature 386:514.
36. Malnati, M. S., M. Peruzzi, K. C. Parker, W. E. Biddison, E. Ciccone, A. Moretta, and E. O. Long. 1995. Peptide specificity in the recognition of MHC class-I by natural killer cell clones. Science 267:1016.
37. Cosman, D., N. Fanger, L. Borges, M. Kubin, W. Chin, L. Peterson, and Mei-Ling Hsu. 1997. A novel immunoglobulin superfamily receptor for cellular and viral MHC class I molecules. Immunity 7:273.
38. Farrel, H. E., H. Vally, D. M. Lynch, P. Fleming, G. R. Shellam, A. A. Scalzo, and N. J. Davis-Poynter. 1997. Inhibition of natural killer cells by a cytomegalovirus MHC class I homologue in vivo. Nature 386:510.